Medinomics Health Care
Home Profile Commitment Mission Strength Contact Us Sitemap
News & Events

Bioequivalence study confirms that our artemether with lumefantrine combination is BIOEQUIVALENT to Coartem.

Malmed and Fantem range launched in Ghana

Malmed and Fantem range launched in Malawi.

Have launch OTC products under Ocean Health & Medical Pvt Ltd in a joint venture with foreign partners.

Completed stability studies for 14 days after reconstitution of FANTEM Suspension ( Artemether 180 with Lumefantrine 1080 ).

Registration of various our antimalarial products is in final stages of approval in FRANCOPHONE COUNTRIES.

Kenya Fantem tablets and Suspension is scheduled to be launched in the month of March 2009.

Fantem range launched in Zambia.

 
Infrastructure
 

Time has witnessed the human cost of the lack of drugs for neglected diseases and has raised its voice against this inequity numerous times. MEDINOMICS HEALTH CARE PVT LTD was established to ensure equitable access to quality products for neglected diseases at affordable prices.

MEDINOMICS will address the unmet needs of patients suffering from the most neglected diseases. Thus, MEDINOMICS will not only contribute in building health of people, eventually, it will also contribute in building healthier future generation.

MEDINOMICS has taken its first step towards its goal by rolling out first batch of New Generation / ACT ANTIMALARIAL medicines as recommended by World Health Organization (W.H.O). New Set of medicines for different diseases will soon be rolled out in phased manner.

As an organization, MEDINOMICS is committed to maintain high standards and culture that values Humanity.

 
© 2010 Medinomics. All Rights Reserved.